Nevirapine toxicity in a cohort of HIV-1-infected pregnant women

被引:28
|
作者
Joäo, EC
Calvet, GA
Menezes, JA
D'Ippolito, MM
Cruz, MLS
Salgado, LAT
Matos, HJ
机构
[1] Hosp Serv Estado, Dept Infect Dis, BR-20221903 Rio De Janeiro, Brazil
[2] Hosp Serv Estado, Dept Obstet, Rio De Janeiro, Brazil
[3] Hosp Serv Estado, Dept Epidemiol, Rio De Janeiro, Brazil
关键词
nevirapine; toxicity; pregnancy; HIV; HCV;
D O I
10.1016/j.ajog.2005.05.015
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective: The purpose of this study was to complete an evaluation of nevirapine (NVP) toxicity in a cohort of HIV+ pregnant women. Study design: This was a retrospective study of 611 women followed from January 1996 to December 2003. All women who used NVP for >7 days were included. Multivariate logistic regression was used to test independent association of CD4 and hepatitis C virus (HCV) infection related to the outcome of toxic effects of NVP. Results: One hundred ninety-seven women were exposed to NVP for > 7 days, and toxicity occurred in 11 (5.6%), leading to drug discontinuation in 7 patients. One case of Stevens-Johnson syndrome Occurred. NO Serious liver toxicity occurred except for I grade 4 cholestasis. Median CD4 was 344 in women without toxicities and 298 in women with toxicities. HCV was the only significant factor associated to toxicity by logistic regression (odds ratio [OR] 15.61, P =.001). Conclusion: NVP toxicities occurred in a very small fraction of patients and were not associated with fatalities. (c) 2006 Mosby, Inc. All rights reserved.
引用
收藏
页码:199 / 202
页数:4
相关论文
共 50 条
  • [1] Population Pharmacokinetics of Nevirapine in HIV-1-Infected Pregnant Women and Their Neonates
    Benaboud, Sihem
    Ekouevi, Didier K.
    Urien, Saik
    Rey, Elisabeth
    Arrive, Elise
    Blanche, Stephane
    Gray, Glenda
    Sim, Kruy Leang
    Avit, Divine
    McIntyre, James
    Nerrienet, Eric
    Dabis, Francois
    Treluyer, Jean-Marc
    Hirt, Deborah
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2011, 55 (01) : 331 - 337
  • [2] Population pharmacokinetics of nevirapine in an unselected cohort of HIV-1-infected individuals
    De Maat, MMR
    Huitema, ADR
    Mulder, JW
    Meenhorst, PL
    Van Gorp, ECM
    Beijnen, JH
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2002, 53 (05) : 552P - 552P
  • [3] Population pharmacokinetics of nevirapine in an unselected cohort of HIV-1-infected individuals
    de Maat, MMR
    Huitema, ADR
    Mulder, JW
    Meenhorst, PL
    van Gorp, ECM
    Beijnen, JH
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2002, 54 (04) : 378 - 385
  • [4] Maraviroc Pharmacokinetics in HIV-1-Infected Pregnant Women
    Colbers, Angela
    Best, Brookie
    Schalkwijk, Stein
    Wang, Jiajia
    Stek, Alice
    Tenorio, Carmen Hidalgo
    Hawkins, David
    Taylor, Graham
    Kreitchmann, Regis
    Burchett, Sandra
    Haberl, Annette
    Kabeya, Kabamba
    van Kasteren, Marjo
    Smith, Elizabeth
    Capparelli, Edmund
    Burger, David
    Mirochnick, Mark
    [J]. CLINICAL INFECTIOUS DISEASES, 2015, 61 (10) : 1582 - 1589
  • [5] Nevirapine use in HIV-1-infected children
    Verweel, G
    Sharland, M
    Lyall, H
    Novelli, V
    Gibb, DM
    Dumont, G
    Ball, C
    Wilkins, E
    Walters, S
    Tudor-Williams, G
    [J]. AIDS, 2003, 17 (11) : 1639 - 1647
  • [6] Nevirapine-associated liver toxicity and hypersensitivity reactions in a cohort of HIV-1-infected patients,clinical analysis
    Sylvie Jonckheere
    JC Yombi
    Leila Belkhir
    Anne Vincent
    Bernard Vandercam
    [J]. Retrovirology, 9
  • [7] Nevirapine-associated liver toxicity and hypersensitivity reactions in a cohort of HIV-1-infected patients, clinical analysis
    Jonckheere, Sylvie
    Yombi, J. C.
    Belkhir, Leila
    Vincent, Anne
    Vandercam, Bernard
    [J]. RETROVIROLOGY, 2012, 9
  • [8] Safety of nevirapine-containing antiretroviral triple therapy regimens to prevent vertical transmission in an African cohort of HIV-1-infected pregnant women
    Marazzi, M. C.
    Germano, P.
    Liotta, G.
    Guidotti, G.
    Loureiro, S.
    Gomes, A. da Cruz
    Blazquez, M. C. Valls
    Narciso, P.
    Perno, C. F.
    Mancinelli, S.
    Palombi, L.
    [J]. HIV MEDICINE, 2006, 7 (05) : 338 - 344
  • [9] Pharmacokinetics of nelfinavir and indinavir in HIV-1-infected pregnant women
    Kosel, BW
    Beckerman, KP
    Hayashi, S
    Homma, M
    Aweeka, FT
    [J]. AIDS, 2003, 17 (08) : 1195 - 1199
  • [10] Pharmacokinetics of nelfinavir in HIV-1-infected pregnant and nonpregnant women
    Villani, P.
    Floridia, M.
    Pirillo, M. F.
    Cusato, M.
    Tamburrini, E.
    Cavaliere, A. F.
    Guaraldi, G.
    Vanzini, C.
    Molinari, A.
    degli Antoni, A.
    Regazzi, M.
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2006, 62 (03) : 309 - 315